InvestorsHub Logo
Followers 7
Posts 1940
Boards Moderated 0
Alias Born 04/10/2016

Re: Rootjim post# 130572

Saturday, 08/19/2017 11:51:56 AM

Saturday, August 19, 2017 11:51:56 AM

Post# of 688742
Isn't that the truth!

With regard to buying more if the phase 3 results are positive (or deciding at what price to dump the shares I hold) it's tough. I'm not convinced this stock will rocket on a successful phase 3 to the extent that many here predict. There is obviously a huge discount applied to this stock for some reason (I have my own theories about that) and I don't see why that would change. A normal company would probably see a nice bump to a multiple billion dollar mc upon successful readout. However, a normal company would also be currently valued several multiples higher than Northwest near the conclusion of a phase 3 trial. I believe diminished value would continue even with phase 3 success due to certain internal issues that will continue to drag down the company.

What if the trial is statistically significant, but OS is only extended a few months? What would that mean for health insurance reimbursement? Btw I'm not convinced ins. coverage for Keytruda, Opdivo, or other immunotherapies with minimal benefit is the right thing for our struggling health care system either..

Anyway, does one sell on a pop to $1 or $2 bucks? IMO, that may be all she's good for. Hope I'm wrong because I would love to at least break even on the pos. I'm just not convinced BP wants anything to do with this technology in terms of a buy out, even if the trial succeeds. Without BP support, does the market see this as DNDN part two and not provide Kite and Juno type euphoria? I dunno...
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News